Using value-based tools to determine the value of bevacizumab in cervical and ovarian cancer
Smith, H.J, Cooper, K, Leath, C.A, Rocque, G.B, Bevis, K.S, Huh, W.K, Straughn, J.M
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
A prognostic nomogram to predict overall survival in women with recurrent ovarian cancer treated with bevacizumab and chemotherapy
Previs, R.A, Bevis, K.S, Huh, W, Tillmanns, T, Perry, L, Moore, K, Chapman, J, McClung, C, Kiet, T, Java, J, Chan, J, Secord, A. Alvarez
Published in Gynecologic oncology (01.03.2014)
Published in Gynecologic oncology (01.03.2014)
Get full text
Journal Article
Knowledge and confidence in gynecologic oncology care among women with ovarian cancer
Pisu, M, Funkhouser, E, Kenzik, K, Rim, S.H, Bevis, K.S, Alvarez, R.D, Martin, M
Published in Gynecologic oncology (01.06.2016)
Published in Gynecologic oncology (01.06.2016)
Get full text
Journal Article
Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma
Montgomery, A.M, Crossman, D.K, Yang, E.S, Alvarez, R.D, Huh, W.K, Bevis, K.S, Straughn, J.M, Leath, C.A, Arend, R.C
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
Gynecologic oncology patients are ready for telemedicine in routine care: Results from a pre-COVID survey
Dholakia, J., Kim, J., Liang, M.I., Arend, R.C., Bevis, K.S., Straughn, J.M., Leath, C.A., Huh, W.K., Smith, H.J.
Published in Gynecologic oncology reports (01.11.2021)
Published in Gynecologic oncology reports (01.11.2021)
Get full text
Journal Article
Improved outcomes following the use of dose-dense paclitaxel-based neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma
Becker, D.A, Gilbert, A.L, Thomas, E.D, Boone, J.D, Straughn, J.M, Huh, W.K, Bevis, K.S, Leath, C.A, Alvarez, R.D
Published in Gynecologic oncology (01.06.2016)
Published in Gynecologic oncology (01.06.2016)
Get full text
Journal Article
The Society of Gynecologic Oncology Clinical Outcomes Registry: A single-institution experience
Lees, B, Straughn, J.M, Hagendoorn, L.J, Arend, R.C, Bevis, K.S, Leath, C.A, Huh, W.K, Alvarez, R.D
Published in Gynecologic oncology (01.06.2016)
Published in Gynecologic oncology (01.06.2016)
Get full text
Journal Article
Optimal according to whom? Interobserver variability in surgical cytoreduction for advanced ovarian carcinoma
Erickson, B.K, Arend, R.C, Walters Haygood, C.L, Philips, C.E, Kennemer, C.R, Leath, C.A, Alvarez, R.D, Straughn, J.M, Bevis, K.S, Huh, W.K
Published in Gynecologic oncology (01.06.2016)
Published in Gynecologic oncology (01.06.2016)
Get full text
Journal Article
Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma
Arend, R.C, Dobbin, Z.C, Crossman, D.K, Erickson, B.K, Boone, J.D, Turner, T.B, Yang, E.S, Alvarez, R.D, Huh, W.K, Bevis, K.S, Straughn, J.M, Estes, J.M, Leath, C.A
Published in Gynecologic oncology (01.06.2016)
Published in Gynecologic oncology (01.06.2016)
Get full text
Journal Article
Utilizing camelid-derived single domain antibodies to enhance immunotherapy of ovarian cancer
van Erp, E.A, Kaliberova, L.N, Kaliberov, S.A, Thomas, E.D, Bevis, K.S, Alvarez, R.D, Curiel, D.T
Published in Gynecologic oncology (01.04.2015)
Published in Gynecologic oncology (01.04.2015)
Get full text
Journal Article
Chemotherapy is a reasonable option for adjuvant therapy in the treatment of high-intermediate risk endometrial cancer
Boone, J, Arend, R.C, Erickson, B.K, Smith, B, Machemehi, H, Straughn, M, Leath, C.A, Bevis, K.S
Published in Gynecologic oncology (01.06.2014)
Published in Gynecologic oncology (01.06.2014)
Get full text
Journal Article
Is observation reasonable in older patients with early-stage uterine papillary serous carcinoma and clear cell carcinoma?
Nguyen, N.A, Arend, R.C, Smith, B, Machemehl, H.C, Fauci, J, Straughn, M, Leath, C.A, Bevis, K.S
Published in Gynecologic oncology (01.06.2014)
Published in Gynecologic oncology (01.06.2014)
Get full text
Journal Article
Disease stabilization versus response after bevacizumab treatment in recurrent ovarian cancer: How do we determine clinical efficacy?
Secord, A.A, Bevis, K.S, Huh, W.K, Blansit, K, Rosenfeld, E, Hu, L, Previs, R.A, Gardner, A.B, Kapp, D.S, Chan, J.K
Published in Gynecologic oncology (01.04.2015)
Published in Gynecologic oncology (01.04.2015)
Get full text
Journal Article
Moderate/severe distress in half of ovarian cancer patients undergoing treatment highlights a need for more proactive symptom and psychosocial management
Wall, J.A., Lipking, K., Smith, H.J., Salter, T., Bevis, K.S., Huh, W., Liang, M.I.
Published in Gynecologic oncology (01.10.2020)
Published in Gynecologic oncology (01.10.2020)
Get full text
Journal Article
Phase IB dose escalation and expansion trial of the oral hedgehog inhibitor sonidegib (LDE225) and weekly paclitaxel in platinum-resistant ovarian cancer (NCT02195973)
Arend, R.C., Bae, S., Doo, D.W., Alvarez, R.D., Straughn, J.M., Bevis, K.S., Estes, J.M., Landen, C.N., Leath, C.A.
Published in Gynecologic oncology (01.06.2018)
Published in Gynecologic oncology (01.06.2018)
Get full text
Journal Article
Does adjuvant treatment increase risk of midurethral sling complications after concomitant surgery for endometrial cancer and stress urinary incontinence?
Kulkarni, A., Proussaloglou, E., Beffa, L.B., Miller, K., Bevis, K.S., Wohlrab, K., Lokich, E., McCourt, C.K., Glaser, G.E., Brown, A.K., Wethington, S.L., Carlson, M.J., DiSilvestro, P.A., Occhino, J.A., Dunivan, G., Tunitsky, E., Chen, G., Raker, C., Luis, C., Robison, K.M.
Published in Gynecologic oncology (01.10.2020)
Published in Gynecologic oncology (01.10.2020)
Get full text
Journal Article